J&J Settlement Ends Latest Pa. Risperdal Case Before Trial

Law360, Philadelphia (November 2, 2016, 4:32 PM EDT) -- Johnson & Johnson agreed to an undisclosed settlement in order to avoid a trial that was slated to begin in Pennsylvania state court on Monday in the latest case over abnormal breast growth that adolescent boys claim they have suffered after taking the antipsychotic drug Risperdal.

The case, which was lodged by the family of a boy — identified only as "N.F." — who allegedly began using Risperdal at age six to treat symptoms of Asperger’s syndrome, was marked as settled by a Philadelphia County judge last Thursday.

“The family is obviously very happy with the result and so are we,”...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!